Transplantation of a fetus with paternal Thy-1+CD34+cells for chronic granulomatous disease
- 1 February 2001
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 27 (4) , 355-364
- https://doi.org/10.1038/sj.bmt.1702798
Abstract
A fetus diagnosed with X-linked chronic granulomatous disease was transplanted with Thy-1+CD34+ cells of paternal origin. The transplant was performed at 14 weeks gestation by ultrasound guided injection into the peritoneal cavity. The fetus was delivered at 38 weeks gestation after an otherwise uneventful pregnancy. Umbilical cord blood was collected and used to determine the level of peripheral blood chimerism as well as levels of functional engrafted cells. Flow cytometry was used to detect donor leukocytes identified as HLA-A2−B7+ cells, whereas recipient cells were identified as HLA-A2+B7− cells. No evidence of donor cell engraftment above a level of 0.01% was found. PCR was used to detect HLA-DRB1*15+ donor cells among the recipient's HLA-DRB1*15− cells, but no engraftment was seen with a sensitivity of 1:1000. The presence of functional, donor-derived neutrophils was assessed by flow cytometry using two different fluorescent dyes that measure reactive oxygen species generated by the phagocyte NADPH oxidase. No evidence of paternal-derived functional neutrophils above a level of 0.15% was observed. Peripheral blood and bone marrow samples were collected at 6 months of age. Neither sample showed engraftment by HLA typing using both flow cytometry and PCR. Functional phagocytes were also not observed. Furthermore, no indication of immunological tolerance specific for the donor cells was indicated by a mixed lymphocyte reaction assay performed at 6 months of age. While there appears to be no engraftment of the donor stem cells, the transplant caused no harm to the fetus and the child was healthy at 6 months of age. Analyses of fetal tissues, obtained from elective abortions, revealed that CD3+ T cells and CD56+CD3− NK cells are present in the liver at 8 weeks gestation and in the blood by 9 weeks gestation. The presence of these lymphocytes may contribute to the lack of donor cell engraftment in the human fetus. Bone Marrow Transplantation (2001) 27, 355–364.Keywords
This publication has 40 references indexed in Scilit:
- Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantationBone Marrow Transplantation, 2000
- Microchimerism and Tolerance following Intrauterine Transplantation and Transfusion for α-Thalassemia-1Fetal Diagnosis and Therapy, 1998
- Development of a Clinically Applicable High-Speed Flow Cytometer for the Isolation of Transplantable Human Hematopoietic Stem CellsJournal of Hematotherapy, 1995
- Expression of the ζ Protein Subunit in CD3- NK Effectors Derived from Human ThymusCellular Immunology, 1994
- Immunomagnetic Separation of CD34+Cells from Human Bone Marrow, Cord Blood, and Mobilized Peripheral BloodJournal of Hematotherapy, 1993
- Fetal B Lymphocyte Subpopulations in Normal PregnanciesFetal Diagnosis and Therapy, 1993
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues.The Journal of Experimental Medicine, 1988
- Development of adult bone marrow stem cells in H-2-compatible and -incompatible mouse fetuses.The Journal of Experimental Medicine, 1984
- PREVENTION OF REJECTION OF ALLOGENEIC BONE MARROW TRANSPLANTS BY NK 1.1 ANTISERUMTransplantation, 1983